Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
The company plans to name an interim chief financial officer effective August 16 as it searches for a permanent CFO.
THE APEX TIMES
THE APEX TIMES
The announcement, reported June 18, 2026, points to continued capital spending by Johnson & Johnson as it expands manufacturing capacity for contact lenses under its consumer health and medical products portfolio.
THE APEX TIMES
The biotech’s stock rose sharply Wednesday, adding to gains from the prior four sessions as investors looked to upcoming remarks at its Investor Day.
THE APEX TIMES
UnitedHealth Group (UNH) ended the latest trading day down 1.99% to $399.53, a larger decline than the overall market, according to a report carried by Yahoo Finance.
THE APEX TIMES
Results from the MonumenTAL-3 study reported by Johnson & Johnson indicate that combining TALVEY with DARZALEX FASPRO improved outcomes versus standard regimens for patients with relapsed or refractory multiple myeloma, according to a report carried by Yahoo Finance.
THE APEX TIMES
After a strong run tied to management raising its outlook, investors are now weighing whether the momentum is durable or simply reflecting a temporary demand and sentiment boost.
THE APEX TIMES
UnitedHealth shares received a boost after Leerink Partners raised its price target, indicating that analysts see early traction in the company’s ongoing efforts to stabilize results and restore confidence.
THE APEX TIMES
Johnson & Johnson says it is moving toward accelerated growth, but one underlying trajectory in its oncology pipeline is drawing close attention from market analysts.
THE APEX TIMES
On CNBC’s Mad Money, Jim Cramer singled out Eli Lilly as a stock he wanted viewers to hold, framing the company as a name worth staying with even as he also discussed other market topics.
